IGF1R and esophageal squamous cell carcinoma: To test if NF‐κB inhibitor could be used in combination with IGF‐1R blocker in treating ESCC, we performed flow cytometry analysis of cell apoptosis in Linsitinib ‐sensitive and ‐resistant cells (Fig. 5).